D2 850 (Jentadueto linagliptin 2.5 mg / metformin hydrochloride 850 mg)
Generic Name: linagliptin/metformin
Pill imprint D2 850 has been identified as Jentadueto linagliptin 2.5 mg / metformin hydrochloride 850 mg.
Jentadueto is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Jentadueto linagliptin 2.5 mg / metformin hydrochloride 850 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- D2 850
- linagliptin 2.5 mg / metformin hydrochloride 850 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Boehringer Ingelheim Pharmaceuticals, Inc.
More about Jentadueto (linagliptin / metformin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.